Scientists have identified a compound that can kill the parasites responsible for three neglected diseases: Chagas disease, leishmaniasis and sleeping sickness.
These diseases affect millions of people in Latin America, Asia and Africa, but there are few effective treatments available.
A new study, published today in Nature, suggests that a single class of drugs could be used to treat all three. Wellcome-funded researchers at the Genomics Institute of the Novartis Research Foundation (GNF) have identified a chemical that can cure all of these diseases in mice. It also does not harm human cells in laboratory tests, providing a strong starting point for drug development.
Chagas, leishmaniasis and sleeping sickness have different symptoms, but are all caused by parasites called ‘kinetoplastids’ – a type of single-celled organism. The parasites share similar biology and genetics, which led scientists to think it might be possible to find a single chemical that could destroy all three.
The team at GNF tested over 3 million different chemicals and identified a compound, GNF6702, which was effective against the parasites but did not damage human cells. They refined this starting compound to make it more potent before testing in it mice.
Senior study author Frantisek Supek from GNF said: “We found that these parasites harbour a common weakness. We hope to exploit this weakness to discover and develop a single class of drugs for all three diseases.”
Dr Stephen Caddick, Director of Innovation at Wellcome, said: “These three diseases lead to more than 50,000 deaths annually, yet they receive relatively little funding for research and drug development. We hope that our early stage support for this research will provide a basis for the development of new treatments that could reduce suffering for millions of people in the poorest regions of the world.”
Existing treatments for the three diseases are expensive, often have side effects and are not very effective. The fact that GNF6702 does not seem to have any adverse effects in mice suggests that it might have fewer side-effects than existing drugs, although this will need to be explored in human studies. GNF6702 is now being tested for toxicity before it can be moved in to clinical trials.
Learn more: A single compound could treat three parasitic diseases
The Latest on: GNF6702
The waste disposal system of parasites: a new target for drugs against neglected tropical diseases - BMC Blogs Network (blog)
September 23, 2016 - In order to find out how this potential drug was killing parasites, the researchers cultivated T. cruzi in the lab in the presence of sub lethal doses of the lead compound GNF6702. By slowly increasing the dose given, they were able to select for ...
Compound, target for fighting three tropical diseases - BioWorld Online
August 13, 2016 - The new compound, GNF6702, came out of a screening effort that looked at the ability of more than 3 million compounds to inhibit the growth of three parasites: Trypanosoma cruzi, which causes Chagas disease, Leishmania donovani, which is the major ...
This new drug could fight 3 of the deadliest infections in developing nations - ScienceAlert
August 12, 2016 - ... get to a cure, and we're working hard in the hope that it gets to patients," she added. "There's been very little incentive to spend a lot of money on these diseases as they affect a very poor, and yet large, population." For now, the drug is known ...
Drei Tropenkrankheiten, ein Wirkstoff - Pharmazeutische Zeitung online
August 11, 2016 - Bei einer Analyse von etwa drei Millionen Substanzen, stießen die Forscher auf eine mit der Bezeichnung GNF6702, die das Proteasom hemmt – ähnlich wie das beim Multiplen Myelom eingesetzte Bortezomib. GNF6702 legt sozusagen die Müllabfuhr lahm, ...
protein inhibitor could treat Chagas, leishmaniasis and sleeping sickness - FierceBiotech
August 10, 2016 - After testing more than 3 million chemicals, they landed on a compound dubbed GNF6702, which destroyed the parasites in mice and did not harm human cells in lab tests, according to a statement. The drug works by selectively inhibiting a protein complex ...
Una cura per leishmaniosi e malattia del sonno, trovato un composto che uccide i parassiti - Tiscali.it
August 10, 2016 - Il composto, nome in codice GNF6702, è stato identificato tra oltre 3 mila testati e risulta fra questi il solo in grado di annientare i parassiti. La sostanza, hanno sottolineato i ricercatori, è stata raffinata e resa più potente. La sperimentazione ...
Santé: une substance prometteuse va peut-être traiter 3 maladies tropicales - RFI
August 9, 2016 - Elle s'appelle GNF6702, et elle pourrait bien être à même de combattre trois maladies tropicales contre lesquelles, pour l'instant, aucun remède efficace n'existe. Des chercheurs viennent d'identifier cette substance capable de tuer les parasites ...
Ученые выявили класс препаратов для борьбы с паразитарными тропическими болезнями - Медицинский вестник
August 9, 2016 - Автор исследования Франтишек Супек (Frantisek Supek) заявляет, что, обнаружив общую слабость паразитов, они смогут разработать класс препаратов для лечения всех трех болезней. В испытниях на мышах GNF6702 не показал никаких ...
Senyawa GNF6702 Mampu Obati Tiga Penyakit Tropis - Harian Analisa (Blog)
August 9, 2016 - Analisadaily - Para ilmuwan telah menemukan senyawa obat yang dapat membunuh parasit untuk tiga penyakit tropis yang mempengaruhi jutaan orang di Afrika, Asia dan Amerika Latin. Disebut GNF6702, senyawa ini mampu mengobati penyakit Chagas, ...
A single compound could treat Chagas disease, leishmaniasis and sleeping sickness - Science Daily
August 8, 2016 - The team at GNF tested over 3 million different chemicals and identified a compound, GNF6702, which was effective against the parasites but did not damage human cells. They refined this starting compound to make it more potent before testing in it mice.